Depressive

Eliem Therapeutics Outlines Interim Data From Early-Stage Depressive Study – Eliem Therapeutics (NASDAQ:ELYM)

Business & Oportunity

Eliem Therapeutics Outlines Interim Data From Early-Stage Depressive Study – Eliem Therapeutics (NASDAQ:ELYM)

By Laverne J. Tiffany 2 years ago

&#13 Eliem Therapeutics Inc ELYM announced interim results from its ongoing Period 1 trial of ETX-155 for important